Venmax Drugs & Pharmaceuticals standalone net profit rises 1460.00% in the March 2025 quarter

Sales reported at Rs 0.33 crore

Net profit of Venmax Drugs & Pharmaceuticals rose 1460.00% to Rs 0.78 crore in the quarter ended March 2025 as against Rs 0.05 crore during the previous quarter ended March 2024. Sales reported to Rs 0.33 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.01 crore in the year ended March 2025 as against net profit of Rs 0.06 crore during the previous year ended March 2024. Sales reported to Rs 0.81 crore in the year ended March 2025. There were no Sales reported during the previous year ended March 2024.

ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales0.330 0 0.810 0 OPM %-72.730 --129.630 - PBDT0.780.06 1200 00.09 -100 PBT0.780.06 1200 -0.010.08 PL NP0.780.05 1460 -0.010.06 PL

Powered by Capital Market - Live News